Fingerprint
Dive into the research topics where Kyoung Eun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study
Ha, H., Chun, S. H., Lee, Y. G., Chang, H., Cho, J. H., Sun, D. S., Cho, S. H., Kwon, J. H., Lee, K. E., Hwang, I. G., Kim, H. J., Keam, B., Shin, S. H., Kim, S. B., Kim, J. H. & Yun, H. J., 2026, In: Cancer Investigation. 44, 5, p. 479-486 8 p.Research output: Contribution to journal › Article › peer-review
-
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
Korean Cancer Study Group (KCSG) Breast Cancer Committee, Oct 2025, In: ESMO Open. 10, 10, 105804.Research output: Contribution to journal › Article › peer-review
Open Access -
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)
Lee, J., Lee, D. W., Kim, M. H., Kim, J. H., Kim, J. W., Byun, J. H., Lee, K. E., Kang, M. J., Koh, S. J., Hong, S., Won, H. S., Kim, H. J., Park, I. H., Shin, S. H., Baek, S. K., Kim, S. G., Koh, S. A., Jung, J. Y., Kim, J. Y. & Kim, G. M. & 5 others, , Aug 2025, In: Breast. 82, 104500.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study
Korean Cancer Study Group (KCSG) Breast Cancer Committee, Mar 2025, In: The Lancet Oncology. 26, 3, p. 343-354 12 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)
Ahn, H. K., Kim, J. H., Koh, S. J., Sohn, J., Kang, M. J., Jung, K. H., Lee, K. E., Lee, J., Koh, S. A., Chae, Y. S., Byun, J. H., Park, I. H., Kim, H. J., Kim, J. H., Kim, H. J., Jung, J. Y., Lee, J. L., Cho, Y. Y., Park, K. H. & Kim, J. Y. & 2 others, , Jul 2025, In: The Lancet Regional Health - Western Pacific. 60, 101622.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations